PD-L1 expression in tumor tissues may have predictive value for PD-1 ICI therapy response in melanoma and other cancers [4, 5], although PD-L1 expression in the tumor tissue does not always correlate with PD-1 ICI therapy response. The gene discussed is PDCD1; the disease is cancer.